By modeling the single-trial electroencephalogram of participants performing perceptual decisions, and building on predictions from two century-old psychological laws, we estimate the times of ...

In early November of this year, I received a request from the Honorable Judge Sharon Soorholtz Greer of the Iowa Court of ...

EASTON — Mid Shore Behavioral Health Inc. hosted its 12th annual sequential intercept mapping model conference on Friday, Nov. 14, at Temple B’Nai Israel in Easton. This year’s theme, “Beyond ...

NOTE: This is the first article in a multi-part series about Henry County’s participation in a Sequential Intercept Model (SIM) Mapping workshop. Additional articles will appear in upcoming issues of ...

Mark Harmon to make rare 'NCIS: Origins' appearance and Gibbs is 'no longer alone' Welcome to Johannesburg. This Is What It Looks Like When a City Gives Up. NATO intercepts Russian spy plane with ...

U.S. fighter jets scrambled Wednesday to intercept four Russian warplanes off the coast of Alaska, the North American Aerospace Defense Command (NORAD) said Thursday. NORAD said in a statement it ...

U.S. fighter jets were scrambled Wednesday to identify and intercept four Russian warplanes flying near Alaska, the North American Aerospace Defense Command said in a statement. NORAD said two Russian ...

While the path for any drug to go from lab research to commercialization takes years, Intercept Pharmaceuticals now stands as another example that a product’s market exit can also be long and winding.

Please provide your email address to receive an email when new articles are posted on . Intercept has voluntarily withdrawn its lone product, Ocaliva, from U.S. market for primary biliary cholangitis.

Sept 11 (Reuters) - Intercept Pharmaceuticals said on Thursday it is withdrawing its liver disease drug from the U.S. market following a request from the Food and Drug Administration. This comes as ...

After years of regulatory struggles for Intercept Pharmaceuticals and its liver disease drug Ocaliva (obeticholic acid), the FDA has called time on the drug's run in the U.S. market. The agency placed ...

Alongside the withdrawal request, the FDA has also placed a clinical hold on all Intercept clinical trials involving obeticholic acid. Intercept Pharmaceuticals has decided to voluntarily withdraw ...